Humans and mice have cyclical regeneration of the endometrial epithelium. It is expected that such regeneration is ensured by tissue stem cells. However, their location remains debatable. A number of recent studies have suggested the presence of stem cells in the mouse endometrial epithelium. At the same time, it has been reported this tissue can be regenerated by stem cells of stromal/mesenchymal or bone marrow cell origin. Here we show that cells expressing transcription factor PAX8 are the main contributor to the homeostatic regeneration of endometrial epithelium. In the uterus, based on a single-cell transcriptome and immunostaining analyses, PAX8 expression is limited to the endometrial epithelium. According to lineage tracing, PAX8 positive (PAX8+) epithelial cells are responsible for long-term maintenance of the epithelium. Furthermore, multicolor tracing shows that individual glands are formed by clonal expansion of cells labeling both glandular and luminal epithelial components. Inactivation of tumor suppressor genes Trp53 and Rb1 in PAX8+ cells but not FOXJ1+ cells leads to formation of neoplasms with features of serous endometrial carcinoma, the most aggressive type of human endometrial malignancy. Taken together, our results show that a progeny of single PAX8+ cells represent the main source of cyclical regeneration of the endometrial epithelium.
Introduction
During reproductive age, in both humans and mice, the endometrial epithelia and stroma undergo cell loss and regrowth in a cyclical manner in response to steroid hormones.
During ovulation, there is an increase in progesterone levels resulting in differentiation of the endometrium with subsequent turnover in the absence of embryo implantation. In humans, this turnover involves endometrial shedding manifested by menstruation. In mice, the turnover is accomplished by cell apoptosis and reabsorption. In both species cyclical homeostatic regeneration of the endometrial epithelium is expected to be maintained by stem cells. However, the presence and location of such cells has been actively debated for the last several decades (reviewed in Gargett et al., 2016; Wang et al., 2019) .
A number of recent studies have suggested location of stem cells in either the glandular (Kaitu'u-Lino et al., 2010) or luminal (Chan and Gargett, 2006; Huang et al., 2012; Jin, 2019) compartments of the mouse endometrial epithelium. In humans, such cells are commonly thought to be located in the basalis segment of the endometrial glands (Nguyen et al., 2012; Patterson et al., 2013; Valentijn et al., 2013) . However, according to a recent single-cell transcriptome study of secretory phase human endometrium, cells showing characteristics of stem/progenitor cells are located in the upper region of the functionalis (Wu et al., 2018) . At the same time, several studies suggested that endometrial epithelium can be regenerated by stem cells of stromal/mesenchymal (Huang et al., 2012; Patterson et al., 2013) or are of bone marrow cell origin (Bratincsak et al., 2007; Du and Taylor, 2007; Ikoma et al., 2009; Mints et al., 2008; Taylor, 2004) .
By analogy with stem cells in other organs and tissues, aberrations in mechanisms governing endometrial epithelial stem cells may lead to a number of pathological conditions, including cancer. Uterine cancer is the 4th most frequent malignancy and the 6th cause of cancer-related deaths in women in the US (Siegel et al., 2019) . While the incidence and mortality rates of some cancers, such as lung and colorectal cancers, are declining, they are both increasing for endometrial carcinoma (Felix et al., 2017; Siegel et al., 2019) . Endometrioid and serous endometrial carcinomas are the most common subtypes, characterized by distinct genetic alterations, pathological phenotypes and clinical behavior. Serous endometrial carcinoma (SEC) is the second most common type of endometrial carcinoma accounting for approximately 10-15% of all cases. SEC often presents at high stage, recurs even after aggressive, adjuvant therapy, and is responsible for the majority of deaths associated with endometrial carcinoma.
Recent extensive integrated genomic analyses of endometrial carcinomas have provided important insights into the repertoire of molecular aberrations characteristic of this malignancy (Berger et al., 2018; Kandoth et al., 2013) . According to TCGA data 77% of endometrioid carcinomas contain mutations in PTEN, but few alterations in TP53
(1.1%) and RB pathway, such as upregulation of CCNE1 (none), CDKN2A (3%), E2F1
(2.2%), CDK2 (none), CDK4 (1.1%), CDK6 (1.1%), and deletion of RB1 (2.2%). SEC have TP53 mutations in 95% of cases (Berger et al., 2018; Kandoth et al., 2013) . Additionally, as the second most common alteration, over 70% of SEC have aberrations, in the RB pathway, involving upregulation of CCNE1 (35%), CDKN2A (18%), E2F1 (18%), CDK2 (17%), CDK4 (7%), and CDK6 (12%), and deletion of RB1 (7%). Unfortunately, utilization of this information is compromised because the originating cell types have not been determined.
Endometrial epithelium-specific knockout of Trp53 in Ksp1.3-Cre expressing cells results in the development of endometrial intraepithelial carcinoma (the precursor of serous carcinoma) and serous carcinoma at 14-16 months of age (Wild et al., 2012) . The use of this model for studies of adult endometrial carcinoma pathogenesis is complicated by constitutive expression of Ksp1.3-Cre in the embryonic precursor structures that give rise to most of the epithelia of the adult genitourinary system.
In the current report we identify PAX8+ cells as the main contributor to homeostatic regeneration of the endometrial epithelium. We also show that neoplasms associated with conditional inactivation of Trp53 and Rb1 in PAX8+ endometrial epithelial cells of adult mice recapitulate human serous endometrial carcinoma.
Results and Discussion
An attempt to establish cell lineage hierarchy of the mouse uterus during development has been reported (Wu et al., 2017) . Unfortunately, the study was focused only on CD326+ epithelial cells isolated by FACS and therefore did not allow identification of other epithelium-specific markers. To identify cells with expression limited to endometrial epithelium, we have analyzed single-cell sequencing data published in the Mouse Cell Atlas (Han et al., 2018) . This atlas contains more than 400,000 single-cell transcriptomic profiles from 51 mouse tissues, organs, and cell cultures, including 3,761 cells from the uterus. For the uterus, in depth analysis of the data was not performed. However, two epithelial clusters were identified and annotated. One cluster was characterized by high
Ltf expression, while the other had high expression of Sprr2f. To improve the resolution of this data we have re-analyzed the Mouse Cell Atlas uterus dataset using our bioinformatic pipeline and a new data normalization method that better accounts for technical noise while preserving biological heterogeneity .
We then prepared a UMAP atlas for the main cell types of the mouse uterus and epithelial subset ( Figure 1 and Figure S1 ). Furthermore, we performed unsupervised SNN clustering and revealed 3 subpopulations ( Figure 1B ). Two groups (0 and 1) had expression of Tacstd2, Klf5, Ly6a, Met, Slc1a3, Wnt7a, Wnt7b, Lpar3, Krt13, and Sprr2f genes. Expression of Itga6 was mainly localized to group 0. According to luminal-specific expression of Tacstd2, Lpar3 and Krt13, this group was annotated as luminal epithelium group. Group 2 was characterized by high expression of Aldh1a1, Foxa2, Lgr 4, Lgr5, Sox17, Axin2, Wif1, Prss29, and Ltf. According to glandular-specific expression of Foxa2
and Prss29 it was annotated as glandular epithelium group. In sum, some markers associated with cell stemness and fate (Tacstd2, Klf5, Ly6a, Met, Slc1a3, Wnt7a, Wnt7b) were detected in the luminal subpopulations while others (Aldh1a1, Foxa2, Lgr 4, Lgr5, Sox17, Axin2) were present in the glandular group. This suggests a possibility that endometrium may contain not one but 2 stem cell pools.
According to single-cell transcriptome analysis, expression of transcription factor PAX8 was largely present in the endometrial epithelium. Immunostaining has shown presence of PAX8 in luminal and glandular epithelial but not stromal cells of the endometrium (Figure 2 ). To further support this observation we used Tg(Pax8-rtTA2S*M2)1Koes/J (Pax8-rtTA) Tg(tetO-Cre)1Jaw/J (Tre-Cre) mice (Perets et al., 2013) crossed to Gt(ROSA)26Sor tm9(CAG-tdTomato)Hze /J (Ai9) reporter mice (Jax Stock No 007909).
In these mice Pax8 promoter drives expression of reverse transactivating protein, rtTA, which in the presence of doxycycline binds to the tetracycline response element (TRE), thereby leading to Cre-loxP mediated activation of the reporter gene in Ai9 mice. In Ai9 mice expression of red fluorescent protein variant (tdTomato) under the control of CAG promoter at the Rosa26 locus is possible only after Cre-mediated deletion of the stop codon flanked by loxP sites (Madisen et al., 2010) . Lineage tracing, using the Pax8-rtTA Tre-Cre (Ai9) mice revealed that the majority of the luminal and glandular epithelium continue to express tdTomato at least for 300 days after the doxycycline pulse. These results support the notion that epithelial cells are responsible for long-term maintenance of the epithelium throughout the estrous cycle.
Using the same Pax8-rtTA Tre-Cre model but with Confetti mice (Gt(ROSA)26Sor tm1(CAG-Brainbow2.1)Cle /J; Jax Stock No 013731) instead of Ai9 reporter mice, we have observed clonal expansion of cells labeling both glands and luminal epithelium by 90 days after Cre induction (Figure 3) . Recent study has reported clonal expansion of normal endometrial epithelial cells with cancer-associated mutations (Suda et al., 2018) .
Thus, our findings provide direct support to the previous report and previously proposed clonal expansion of endometrial epithelium. Further studies will be required to test if such expansion is a result of a neutral competition between endometrial epithelial stem cells, as has been shown for Lgr5+ cells in the small intestine (Snippert et al., 2010) .
Since SEC have TP53 mutations in 95% of cases and alterations in Rb pathway in over 70% of cases, we have conditionally inactivated Trp53 and Rb1 in the endometrial epithelium in composite Pax8-rtTA TRE-Cre p53 loxP/loxP Rb loxP/loxP Ai9 mice (Figure 4 ). Use of these mice allows direct visualization of cells exposed to Cre expression ( Figure S2 ).
We administered a single I.P. injection of doxycycline to adult mice (6-8 weeks old) and observed formation of neoplasms starting 120 days after doxycycline administration. (Cochrane et al., 2017) . As compared to SEC, clear cell endometrial carcinomas have lower frequency of TP53 mutilations (30-40% vs 95%) but contain other alterations, such as microsatellite instability (15% vs 5%) and PTEN mutations (30% vs 10%) DeLair et al., 2017; Lax et al., 1998) . We also cannot exclude that luminal not glandular cells represent the cell of origin of SEC.
Our current analysis of single-cell transcriptome data was based on metestrus epithelium. Further studies will evaluate cell lineage dynamics during the full estrous cycle. Our findings support existence of endometrial epithelial stem cells. However they cannot completely exclude non-epithelial contributions under non-homeostatic conditions, such as postpartum endometrial regeneration and artificial decidualization (Huang et al., 2012; Patterson et al., 2013) . None of the studies reporting contributions of bone-marrow derived cells (Bratincsak et al., 2007; Du and Taylor, 2007; Ikoma et al., 2009; Mints et al., 2008; Taylor, 2004) included experiments testing for cell fusion, which is a common reason for detection of bone-marrow-specific markers in non-hematopoietic tissues. Thus, these results await further confirmation.
The main strengths of autochthonous genetically modified mouse models of cancer include precise control of initiating genetic alterations and ability to study cancer initiation and progression in an immunocompetent environment (Day et al., 2015; HogenEsch and Nikitin, 2012) . Our new model of SEC confirms critical role of TP53 mutations and RB1 pathway alterations in the pathogenesis of this disease. It also offers a valuable tool for future fundamental and translational studies.
Methods

Experimental animals
The Tg(Pax8-rtTA2S*M2)1Koes/J (Pax8-rtTA) Tg(tetO-Cre)1Jaw/J (Tre-Cre) mice (Perets et al., 2013) , 
Histology, immunohistochemistry and image analysis
All tissues were fixed in buffered 4% paraformaldehyde overnight at 4°C followed by standard tissue processing and paraffin embedding. Histology and immunohistochemistry stainings were carried out on 4 μm-thick tissue sections. For immunohistochemistry, antigen retrieval was performed by incubation of deparaffinized and rehydrated tissue sections in boiling 10 mM sodium citrate buffer (pH 6.0) for 10 minutes. The primary antibodies against ER, FOXA2, Ki67, P16, PAX8, PR, tdTomato/RFP, TP53 and TROP2 were incubated at 4°C for overnight, followed by incubation with secondary biotinylated antibodies (30 minutes, at room temperature, RT). Modified Elite avidin-biotin peroxidase (ABC) technique (Vector Laboratories, Burlingame, CA, USA; pk-6100) was performed at RT for 30 minutes. Hematoxylin was used as the counterstain. All primary antibodies used for immunostaining are listed in Supplementary Table 1 .
Single cell transcriptome analysis
The Mouse Cell Atlas (Han et al., 2018) digital expression matrices for uterus (Uterus1 GEO: GSM2906478 and Uterus2 GEO: GSM2906479) and related cell type metadata were downloaded (GEO: GSE108097) and reanalyzed using a custom version of Seurat version 3.1.0 R package (Stuart et al., 2019) . Seurat was used for data integration and normalization, principal component reduction, shared nearest neighbor (SNN) clustering, UMAP visualization, and differential gene expression analysis. We combined the Uterus1 and Uterus2 datasets and normalized the data using a regularized negative binomial regression model (sctransform R package) in order to remove technical effects while preserving biological variability . On the normalized data, 13 we performed SSN clustering with a resolution of 0.4 and we visualized the data using uniform manifold approximation and projection (UMAP) (Becht et al., 2018) . Differential expression analysis was performed using Seurat's "FindAllMarkers" function using a wilcoxon signed-rank test and only considering genes with >log2(0.25) fold-change and expressed in at least 25% of cells in the cluster.
Patient materials
All human specimens were de-identified. They were not collected specifically for the purpose of this research.
Statistical analyses
Statistical comparisons were performed using a two-tailed unpaired t test and a Chi square test with InStat 3 and Prism 6 software (GraphPad Software Inc., La Jolla, CA, USA). Survival curves were computed using the Kaplan-Meier method and the survival comparisons were analyzed by log-rank tests. Significance was determined as P<0.05. 
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